WAO INDIA,
You can collect $ 1 per day from PTC this one ( WAO INDIA). Given the ability to pay is high enough that the $ 0.1-per-click ads that you do and $ 0.05 per click ads that do your refferal.
So, If you are a standard member click 10 ads per day and 20 refferal you click 10 ads per day, your earnings potential can be calculated as follows:
You click 10 ads per day = $ 1
20 refferal click 10 ads per day = $ 10
YouR Earning/ per month = $ 330
Indeed, most people consider this PTC scam, because too high in the case of preferred payment, so it does not seem rational and fable-like mock or play the end of the not responsible or scam. But if you go to forum Waoindia, you can see how many of the member who has obtained incomes from this PTC.
Below is a passage about the reasons why the post WaoIndia afford to pay high to the members.
So they can afford the high PTC because this is not personal property, but like most in PTC have a corporate that by working with 2 the big company off advertisers big sky development (microsoft partner, type in the website development sky microsoft.com) and domainonair the brave 0:15 pay per click ads (probably cheaper if you use Google AdWords). This means that each click is done without a member sponsor WaoIndia profit $ 0.05. Although invisible, but if you see a small number of the member so big plus value hitz so high that they can earn in WaoIndia is very large. So even though WaoIndia members pay $ 0.1 is already get profit $ 0.05-per-click ads.
Payment (payout) to the members made by Paypal, alertpay and check after reaching the minimum standard payout is $ 199. For more details can be found in the FAQ in the member area WaoIndia.
From the facts above, the presence WaoIndia is additional opportunity for online business, especially the 'penggila' PTC.
DONT WOrRY until now its Free, Join now before too late,
After joined dont forget to tell your frinds and dont forget clicks ads / day.
1) Refer every 10 user under your downline & earn $ 2 bonus.
2) 50% Referral earning any instant when your referred users visit any advertise.
3) Referral earning 20% on net sale price any instant when a referred user paid for anything.
Monsterbux until now isnot SCAM ,there is many people get paid..i already signed in..Do You ?
At MonsterBux.com, you get paid to click on ads and visit websites.
The process is easy! You simply click a link and view a website for 20 seconds to earn money. You can earn even more by referring friends. You'll get paid $0.01 for each website you personally view and $0.005 for each website your referrals view. Payment requests can be made every day and are processed through Paypal & AlertPay. The minimum payout is $10.00. GET PAID WITHIN 24 Business Hours with our New Payment System!
Earnings Example
� You click 20 ads per day = $0.1
� 20 referrals click 10 ads per day = $1
� Your daily earnings = $1.1
� Your weekly earnings = $7.7
� Your monthly earnings = $33
� Your total annual earnings = $396
The above example is based only on 20 referrals and 10 daily clicks. Some days you will have more clicks available, some days you will have less. What if you had more referrals? What if there were more ads available?
nb: please check in other forum and milist about this PTC
Before you read this article ,please read this article too ( how about add multiple colomn for footer template TurnOutmag).Now i introduce to you How to make relatedpost for all article .So anyone who want read your article can easy searching your all article and can get more traffic for our blog.
The original template of turnoutmag we will find this script :
<DIV expr:id='"summary" + data:post.id'><p><data:post.body/></p></DIV> <SCRIPT type='text/javascript'>createSummaryAndThumb("summary<data:post.id/>");</SCRIPT>
<div style='clear: both;'/> <!-- clear for photos floats -->
</div>
<p class='details2'>
<b:if cond='data:blog.pageType != "item"'><b:if cond='data:post.allowComments'>
<a class='comment-link' expr:href='data:post.addCommentUrl' expr:onclick='data:post.addCommentOnclick'><b:if cond='data:post.numComments == 1'><data:top.commentLabel/> (1)<b:else/><data:top.commentLabelPlural/> (<data:post.numComments/>)</b:if></a>
</b:if>
</b:if> / <a expr:href='data:post.url'>Read More</a></p>
</div>
<b:else/><!-- BEGIN content -->
<div id='contentb'><div class='single'>
<h2><data:post.title/></h2>
<div class='contentb'><p><data:post.body/></p>
</div>
</div>
So change that codewith this one.Aware before you change your template you must backup your template.
<DIV expr:id='"summary" + data:post.id'><p><data:post.body/></p></DIV> <SCRIPT type='text/javascript'>createSummaryAndThumb("summary<data:post.id/>");</SCRIPT>
<div style='clear: both;'/> <!-- clear for photos floats -->
</div>
<p class='details2'>
<b:if cond='data:blog.pageType != "item"'><b:if cond='data:post.allowComments'>
<a class='comment-link' expr:href='data:post.addCommentUrl' expr:onclick='data:post.addCommentOnclick'><b:if cond='data:post.numComments == 1'><data:top.commentLabel/> (1)<b:else/><data:top.commentLabelPlural/> (<data:post.numComments/>)</b:if></a>
</b:if>
</b:if> / <a expr:href='data:post.url'>Read More</a></p>
</div>
<b:else/><!-- BEGIN content -->
<div id='contentb'><div class='single'>
<h2><data:post.title/></h2>
<div class='contentb'><p><data:post.body/></p>
<!--relatedpost-->
<b:if cond='data:blog.pageType == "item"'>
<div class='similiar'><div class='widget-content'>
<h3>Related Posts by Categories</h3>
<div id='data2007'/><br/><br/>
<script type='text/javascript'>var homeUrl3 = "<data:blog.homepageUrl/>";
var maxNumberOfPostsPerLabel = 4;
var maxNumberOfLabels = 10;maxNumberOfPostsPerLabel = 100;
maxNumberOfLabels = 3;function listEntries10(json) {
var ul = document.createElement('ul');
var maxPosts = (json.feed.entry.length <= maxNumberOfPostsPerLabel) ?
json.feed.entry.length : maxNumberOfPostsPerLabel;
for (var i = 0; i < maxPosts; i++) {
var entry = json.feed.entry[i];
var alturl;for (var k = 0; k < entry.link.length; k++) {
if (entry.link[k].rel == 'alternate') {
alturl = entry.link[k].href;
break;
}
}
var li = document.createElement('li');
var a = document.createElement('a');
a.href = alturl;if(a.href!=location.href) {
var txt = document.createTextNode(entry.title.$t);
a.appendChild(txt);
li.appendChild(a);
ul.appendChild(li);
}
}
for (var l = 0; l < json.feed.link.length; l++) {
if (json.feed.link[l].rel == 'alternate') {
var raw = json.feed.link[l].href;
var label = raw.substr(homeUrl3.length+13);
var k;
for (k=0; k<20; k++) label = label.replace("%20", " ");
var txt = document.createTextNode(label);
var h = document.createElement('b');
h.appendChild(txt);
var div1 = document.createElement('div');
div1.appendChild(h);
div1.appendChild(ul);
document.getElementById('data2007').appendChild(div1);
}
}
}
function search10(query, label) {var script = document.createElement('script');
script.setAttribute('src', query + 'feeds/posts/default/-/'
+ label +
'?alt=json-in-script&callback=listEntries10');
script.setAttribute('type', 'text/javascript');
document.documentElement.firstChild.appendChild(script);
}var labelArray = new Array();
var numLabel = 0;<b:loop values='data:posts' var='post'>
<b:loop values='data:post.labels' var='label'>
textLabel = "<data:label.name/>";var test = 0;
for (var i = 0; i < labelArray.length; i++)
if (labelArray[i] == textLabel) test = 1;
if (test == 0) {
labelArray.push(textLabel);
var maxLabels = (labelArray.length <= maxNumberOfLabels) ?
labelArray.length : maxNumberOfLabels;
if (numLabel < maxLabels) {
search10(homeUrl3, textLabel);
numLabel++;
}
}
</b:loop>
</b:loop>
</script>
</div></div>
</b:if><!-- end relatedP-->
</div>
</div>
Now “ PREVIEW” your blog, if success you can Save your new template.
Commonly we can add relatedpost at fisrt script to <p><data:post.body/></p> before “READMORE” ,because there is two script <p><data:post.body/></p>
<DIV expr:id='"summary" + data:post.id'><p>
<data:post.body/></p></DIV> <SCRIPT type='text/javascript'>createSummaryAndThumb("summary<data:post.id/>");</SCRIPT>
<div style='clear: both;'/> <!-- clear for photos floats -->
</div>
<p class='details2'>
<b:if cond='data:blog.pageType != "item"'><b:if cond='data:post.allowComments'>
<a class='comment-link' expr:href='data:post.addCommentUrl' expr:onclick='data:post.addCommentOnclick'><b:if cond='data:post.numComments == 1'><data:top.commentLabel/> (1)<b:else/><data:top.commentLabelPlural/> (<data:post.numComments/>)</b:if></a>
</b:if>
</b:if> / <a expr:href='data:post.url'>Read More</a></p>
</div>
<b:else/><!-- BEGIN content -->
<div id='contentb'><div class='single'>
<h2><data:post.title/></h2>
<div class='contentb'> <p><data:post.body/></p>
So well done..
Please leave your comment ,advise me
regards
Info Medical
CLOPIDOGREL
Clopidogrel 75 mg equivalent clopidogrel hydrogen sulphate 97.875 mg
Plavix (clopidogrel bisulfate) is an inhibitor of ADP-induced platelet aggregation acting by direct inhibition of adenosine diphosphate (ADP) binding to its receptor and of the subsequent ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. Chemically it is methyl (+)-(S)-α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate sulfate (1:1). The empirical formula of clopidogrel bisulfate is C16H16ClNO2S•H2SO4 and its molecular weight is 419.9.
The structural formula is as follows:
Plavix (clopidogrel bisulfate) is indicated for the reduction of atherothrombotic events as follows:
- Recent MI, Recent Stroke or Established Peripheral Arterial Disease
For patients with a history of recent myocardial infarction (MI), recent stroke, or established peripheral arterial disease, Plavix has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new MI (fatal or not), and other vascular death. - Acute Coronary Syndrome
For patients with non-ST-segment elevation acute coronary syndrome (unstable angina/non-Q-wave MI) including patients who are to be managed medically and those who are to be managed with percutaneous coronary intervention (with or without stent) or CABG, Plavix has been shown to decrease the rate of a combined endpoint of cardiovascular death, MI, or stroke as well as the rate of a combined endpoint of cardiovascular death, MI, stroke, or refractory ischemia.
For patients with ST-segment elevation acute myocardial infarction, Plavix has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke. This benefit is not known to pertain to patients who receive primary angioplasty.
DOSAGE
ADULT and Ederly
Just single daily of 75 mg clopidogrel with or without food
Non-ST segment elevation (unstable angina/non-Q-wave MI) should be initiated with a single 300-mg loading dose and then continued at 75 mg once daily. Aspirin (75 mg-325 mg once daily) should be initiated and continued in combination with Plavix.
in Indonesian country only have
PLAVIX 75 MG( sanofi) contain 30’s tablet/box
and now there is other competitor such as
CPG 75 MG
I am glad now ,for clopidogrel(plavix) is include in packed ASKES( Asuransi kesehatan) from Indonesia.
Viagra
Trade name of an orally administered drug for erectile failure first cleared for marketing in the United States in March 1998. Its generic name is sildenafil citrate.
Mentioned in: Impotence
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.
trademark for a preparation of sildenafil citrate, a treatment for erectile dysfunction.
Mosby's Medical Dictionary, 8th edition. © 2009, Elsevier.
sildenafil citrate
Revatio, Viagra
Pharmacologic class: Phosphodiesterase type 5 (PDE5) inhibitor
Therapeutic class: Anti-erectile dysfunction agent
Pregnancy risk category B
Action
Inhibits PDE5, enhancing the effects of nitric oxide released during sexual stimulation. This action inactivates cyclic guanosine monophosphate (cGMP), which then increases cGMP levels in corpus cavernosum. Resulting smooth muscle relaxation promotes increased blood flow and subsequent erection.
Availability
Tablets: 25 mg, 50 mg, 100 mg
⊘Indications and dosages
➣ Erectile dysfunction
Adults: 50 mg P.O., preferably 1 hour before anticipated sexual activity. Range is 25 to 100 mg taken 30 minutes to 4 hours before sexual activity, not to exceed one dose daily.
Dosage adjustment
• Hepatic or renal impairment
• Concurrent use of hepatic isoenzyme inhibitors (such as cimetidine, erythromycin, itraconazole, ketoconazole)
• Elderly patients
Contraindications
• Hypersensitivity to drug
• Concurrent use of nitrates (nitroglycerin, isosorbide mononitrate or dinitrate)
Precautions
Use cautiously in:
• serious cardiovascular disease (such as history of myocardial infarction, cerebrovascular accident, or serious arrhythmia within past 6 months); coronary artery disease (current or previous) with unstable angina; resting blood pressure below 90/50 mm Hg or above 170/110 mm Hg (current or previous); heart failure (current or previous); renal or hepatic impairment (current or previous); bleeding disorder; active peptic ulcer; anatomic penile deformity; retinitis pigmentosa; conditions associated with priapism (sickle cell anemia, multiple myeloma, leukemia)
• history of uncontrolled hypertension or hypotension
• concurrent use of antihypertensives, erythromycin, ketoconazole, itraconazole, or saquinavir
• patients older than age 65.
Administration
☞ Don't give concurrently with nitrates.
• Administer 30 minutes to 4 hours before sexual activity.
Route Onset Peak Duration
P.O. Within 1 hr Unknown Up to 4 hr
Adverse reactions
CNS: headache, dizziness, anxiety, drowsiness, vertigo, seizures , cerebrovascular hemorrhage, transient ischemic attack
CV: hypertension, myocardial infarction (MI), cardiovascular collapse, ventricular arrhythmias, sudden death
EENT: transient vision loss, blurred or color-tinged vision, increased light sensitivity, ocular redness, retinal bleeding, vitreous detachment or traction, photophobia, nasal congestion
GI: diarrhea, dyspepsia
GU: hematuria, urinary tract infection, priapism
Skin: flushing, rash
Interactions
Drug-drug. Antihypertensives, nitrates: increased risk of hypotension
Enzyme inducers, rifampin: reduced sildenafil blood level
Hepatic isoenzyme inhibitors (such as cimetidine, erythromycin, itraconazole, ketoconazole), protease inhibitors (such as indinavir, nelfinavir, ritonavir, saquinavir): increased sildenafil blood level and effects
Drug-food. High-fat diet: reduced drug absorption, decreased peak level
Patient monitoring
• Monitor cardiovascular status carefully.
• Evaluate patient's vision.
• Assess for drug efficacy.
Patient teaching
• Advise patient to take 30 minutes to 4 hours before sexual activity.
• Tell patient not to exceed prescribed dosage or take more than one dose daily.
☞ Instruct patient to stop sexual activity and contact prescriber immediately if chest pain, dizziness, or nausea occurs.
☞ Teach patient to recognize and immediately report serious cardiac and vision problems.
• Inform patient that drug can cause serious interactions with many common drugs. Instruct him to tell all prescribers he's taking it.
☞ Caution patient never to take drug with nitrates, because of risk of potentially fatal hypotension.
• Instruct patient to report priapism (persistent, painful erection) or erections lasting more than 4 hours.
• Tell patient that high-fat diet may interfere with drug efficacy.
• Caution patient to avoid driving and other hazardous activities until he knows how drug affects concentration and alertness.
• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs and foods mentioned above.
